Serum vitamin D metabolites do not differ between cats with chronic kidney disease and healthy cats

Valerie Parker1, Lauren J Reynolds1, Jessica M Quimby1

  • 1Department of Veterinary Clinical Sciences, The Ohio State University, Columbus, OH, USA.

Insights

Vitamin D metabolite levels in cats with chronic kidney disease (CKD) did not differ significantly from healthy cats. This finding suggests current calcitriol supplementation recommendations may need re-evaluation for feline CKD patients.

Area of Science:

  • Veterinary Medicine
  • Nephrology
  • Endocrinology

Background:

  • Chronic kidney disease (CKD) is common in cats and can affect vitamin D metabolism.
  • Understanding vitamin D metabolite profiles is crucial for managing feline CKD.
  • Previous research has not comprehensively characterized these profiles in cats with varying stages of CKD.

Purpose of the Study:

  • To compare serum concentrations of key vitamin D metabolites in cats with CKD versus healthy controls.
  • To investigate potential correlations between vitamin D metabolites and clinicopathologic parameters in cats.

Main Methods:

  • Serum samples were collected from 66 cats with CKD (IRIS stages 1-4) and 33 healthy cats.
  • Concentrations of 25-hydroxyvitamin D3, 3-epi-25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3 (calcitriol), and 24,25-dihydroxyvitamin D3 were measured using LC-MS/MS.
  • Statistical analyses included Mann Whitney or t tests for group comparisons and Spearman rank tests for correlations.

Main Results:

  • No significant differences were observed in any measured vitamin D metabolite between cats with CKD and healthy cats.
  • Specific median concentrations for 25(OH)D3, 3-epi-25(OH)D3, calcitriol, and 24,25(OH)2D3 are provided for both groups.
  • No correlations were found between vitamin D metabolites and age, serum creatinine, hematocrit, blood pressure, or urine protein:creatinine ratio.

Conclusions:

  • Serum vitamin D metabolite concentrations are similar in cats with CKD and healthy cats.
  • These findings may influence current recommendations for calcitriol supplementation in feline CKD.
  • Further research is warranted to fully understand vitamin D dynamics in feline CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...